Wolfgang Hiddemann

Wolfgang Hiddemann

UNVERIFIED PROFILE

Are you Wolfgang Hiddemann?   Register this Author

Register author
Wolfgang Hiddemann

Wolfgang Hiddemann

Publications by authors named "Wolfgang Hiddemann"

Are you Wolfgang Hiddemann?   Register this Author

100Publications

4138Reads

9Profile Views

Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.

Haematologica 2019 Aug 1. Epub 2019 Aug 1.

School of Pharmacy, University of Southern California, Los Angeles, CA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.207001DOI Listing
August 2019

Frequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice.

Leuk Lymphoma 2019 Mar 20;60(3):848-851. Epub 2018 Sep 20.

a Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Center Munich , German Research Center for Environmental Health , Munich , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1509314DOI Listing
March 2019

High prevalence of moral distress reported by oncologists and oncology nurses in end-of-life decision making.

Psychooncology 2018 12 20;27(12):2733-2739. Epub 2018 Sep 20.

Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pon.4868
Publisher Site
http://dx.doi.org/10.1002/pon.4868DOI Listing
December 2018

[Diagnosis and Therapy of Leukemia: a Result of Groundbreaking Research].

Dtsch Med Wochenschr 2018 09 10;143(18):1281. Epub 2018 Sep 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-121024DOI Listing
September 2018

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.

J Clin Oncol 2018 08 1;36(23):2395-2404. Epub 2018 Jun 1.

Wolfgang Hiddemann and Roswitha Forstpointner, University Hospital, Ludwig Maximilian University Munich, Munich; Jan Dürig, University Hospital Essen, Essen; Michael Herold, HELIOS-Klinikum Erfurt, Erfurt, Germany; Anna Maria Barbui, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; Miguel A. Canales, Hospital Universitario la Paz, Madrid, Spain; Paul K. Cannell, Fiona Stanley Hospital, Murdoch, Western Australia; Mark Hertzberg, Prince of Wales Hospital; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales; John F. Seymour, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Victoria, Australia; Graham P. Collins, Churchill Hospital, Oxford; John Radford, University of Manchester and the Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester; Robert E. Marcus, Kings College Hospital, London, United Kingdom; Magdalena Klanova, Charles University General Hospital, Prague, Czech Republic; Magdalena Klanova, Alis Burciu, Günter Fingerle-Rowson, Marcel Wolbers, and Tina Nielsen, F. Hoffmann-La Roche, Basel, Switzerland; and Kensei Tobinai, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8960DOI Listing
August 2018

[Immune Therapy in Oncology: Are we Approaching the Breakthrough?]

Dtsch Med Wochenschr 2018 Jul 13;143(14):993. Epub 2018 Jul 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0549-6862DOI Listing
July 2018

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.

Biol Blood Marrow Transplant 2018 06 29;24(6):1172-1179. Epub 2018 Mar 29.

Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Centre (DKFZ), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.03.022DOI Listing
June 2018

Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell lines.

Eur J Haematol 2018 Apr 4. Epub 2018 Apr 4.

Department of Medicine III, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13075DOI Listing
April 2018

[Aspects of Palliative Care: Finding the Right Balance].

Dtsch Med Wochenschr 2018 Apr 12;143(8):537. Epub 2018 Apr 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-114498DOI Listing
April 2018

"Rather one more chemo than one less…": Oncologists and Oncology Nurses' Reasons for Aggressive Treatment of Young Adults with Advanced Cancer.

Oncologist 2018 02 13;23(2):256-262. Epub 2017 Nov 13.

Department of Medical Oncology, National Center for Tumor Diseases, Programme for Ethics and Patient-Oriented Care in Oncology, Heidelberg University Hospital, Heidelberg, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813748PMC
February 2018

The second patient? Family members of cancer patients and their role in end-of-life decision making.

BMC Palliat Care 2018 Feb 17;17(1):29. Epub 2018 Feb 17.

National Center for Tumor Diseases, Department of Medical Oncology, Programme for Ethics and Patient-Oriented Care in Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12904-018-0288-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816525PMC
February 2018

Obinutuzumab Treatment of Follicular Lymphoma.

N Engl J Med 2017 12;377(26):2605-2606

Ludwig-Maximilians-University Hospital, Munich, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1714337#SA2DOI Listing
December 2017

Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.

Br J Haematol 2017 11 18;179(3):480-487. Epub 2017 Aug 18.

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14901DOI Listing
November 2017

[Precision Oncology: Approaching the Target].

Dtsch Med Wochenschr 2017 11 27;142(22):1637. Epub 2017 Oct 27.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-114489DOI Listing
November 2017

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

N Engl J Med 2017 10;377(14):1331-1344

From King's College Hospital (R.M.) and the Cancer Research UK and University College London Cancer Trials Centre (E.P., W.T.), London, and the Cancer Research UK Centre, University of Southampton, Southampton (A.D.) - all in the United Kingdom; the Tokai University School of Medicine, Isehara, Japan (K.A.); the University of Kiel, Kiel (W.K.), Gemeinschaftspraxis, Würzburg (R. Schlag), HELIOS Klinikum Erfurt, Erfurt (M.H.), and the Ludwig-Maximilians-University Hospital Grosshadern, Munich (W.H.) - all in Germany; Monash Health and Monash University (S.O.) and the Peter MacCallum Cancer Centre and University of Melbourne (J.F.S.), Melbourne, VIC, Australia; Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, AB (C.O.), and the Cross Cancer Institute, Edmonton, AB (R. Sangha) - both in Canada; Charles University, Prague, Czech Republic (M.T.); and F. Hoffmann-La Roche, Basel, Switzerland (M.W., G.F.-R., K.R., T.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614598DOI Listing
October 2017

Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014.

PLoS One 2017 6;12(4):e0175124. Epub 2017 Apr 6.

Department of Palliative Medicine, Munich University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175124PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383201PMC
September 2017

Therapy of older persons with acute myeloid leukaemia.

Leuk Res 2017 09 1;60:1-10. Epub 2017 Jun 1.

University Hospital Münster, Department of Medicine A, Albert-Schweitzer-Campus 1, Geb. A1, 48129 Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.05.020DOI Listing
September 2017

[Frequency and Timing of Decisions to Limit Intensive Medical Care and Tumor-Specific Therapy in University Hematology and Oncology].

Dtsch Med Wochenschr 2017 Sep 29;142(17):e116-e123. Epub 2017 Aug 29.

Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Medizinische Onkologie, Universitätsklinikum Heidelberg, Schwerpunkt "Ethik und Patientenorientierung in der Onkologie".

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-103340DOI Listing
September 2017

[Complementary Therapies for Cancer].

Dtsch Med Wochenschr 2017 Jun 21;142(12):857. Epub 2017 Jun 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-104814DOI Listing
June 2017

Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.

Exp Hematol 2017 03 5;47:54-63. Epub 2016 Nov 5.

Department of Medicine III, University of Munich, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.10.012DOI Listing
March 2017

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.

J Clin Oncol 2017 Feb 28;35(5):552-560. Epub 2016 Dec 28.

Qian Shi and Daniel J. Sargent, Mayo Clinic, Rochester; Bruce A. Peterson, University of Minnesota, Minneapolis, MN; Christopher R. Flowers, Winship Cancer Institute of Emory University, Atlanta, GA; Wolfgang Hiddemann and Eva Hoster, Ludwig-Maximilians University Hospital, Munich; Michael Herold, HELIOS Kliniken, Erfurt, Germany; Robert Marcus, Addenbrooke's Hospital, Cambridge, United Kingdom; Anton Hagenbeek, Academic Medical Center, Amsterdam, the Netherlands; Eva Kimby, Karolinska Institutet, Stockholm, Sweden; Howard Hochster, Yale Cancer Center, New Haven, CT; Umberto Vitolo, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin; Marco Ladetto, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Emmanuel Gyan, University Hospital, Tours; Franck Morschhauser, Service Université de Lille 2, Lille; Gilles Salles, Université Claude Bernard, Pierre Bénite, France; Michele Ghielmini and Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona; Michele Ghielmini and Emanuele Zucca, Swiss Group for Clinical Cancer Research, Bern; Tina Nielsen, F. Hoffmann-La Roche, Basel; Sabine De Bedout, Celgene, Boudry, Switzerland; Tommy Fu, Celgene, Summit, NJ; Nancy Valente, Genentech, South San Francisco, CA; and Nathan H. Fowler, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8651DOI Listing
February 2017

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.

Cancer Cell 2016 Dec 1;30(6):849-862. Epub 2016 Dec 1.

Department of Gene Vectors, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), 81377 Munich, Germany; German Consortium for Translational Cancer Research (DKTK), Partnering Site, Munich, 81377 Munich, Germany; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University München, 80337 Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156313PMC
December 2016

Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia.

Exp Hematol 2016 Nov 26;44(11):1039-1043.e10. Epub 2016 Jul 26.

Research Institute of the McGill University Health Centre and McGill University, Montreal, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.07.012DOI Listing
November 2016

Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathway.

Leuk Lymphoma 2015 3;56(12):3393-400. Epub 2015 Aug 3.

a Department of Internal Medicine III , University Hospital Munich-Großhadern , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1023720DOI Listing
September 2016

Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.

J Clin Virol 2016 09 10;82:33-40. Epub 2016 Jul 10.

Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2016.07.002DOI Listing
September 2016

Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel.

Ann Hematol 2016 Aug 28;95(8):1281-6. Epub 2016 May 28.

Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel/Christian-Albrecht University, Arnold-Heller-Str. 3, Haus 14, 24105, Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2704-0DOI Listing
August 2016

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Blood 2016 08 10;128(5):686-98. Epub 2016 Jun 10.

Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-693879DOI Listing
August 2016

Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.

Genes Chromosomes Cancer 2016 07 2;55(7):553-67. Epub 2016 May 2.

Experimental Leukemia and Lymphoma Research (ELLF), Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22359DOI Listing
July 2016

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.

Cell Rep 2016 07 23;16(2):498-507. Epub 2016 Jun 23.

Institute of Experimental Cancer Research, CCC and University Hospital of Ulm, 89081 Ulm, Germany; Core Facility Genomics, Medical Faculty Ulm, Ulm University, 89081 Ulm, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.05.094DOI Listing
July 2016

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.

J Clin Oncol 2016 Apr 29;34(12):1386-94. Epub 2016 Feb 29.

Eva Hoster, Roswitha Forstpointner, Christian Schmidt, Wolfgang Hiddemann, Michael Unterhalt, and Martin H. Dreyling, University Hospital Munich; Eva Hoster, University of Munich, Munich; Andreas Rosenwald, University of Würzburg, Würzburg; Heinz-Wolfram Bernd, University Hospital Schleswig-Holstein, Lübeck; Sylvia Hartmann, University Hospital of Frankfurt, Frankfurt am Main; Christoph Loddenkemper, University Hospital Berlin Charité; Christoph Loddenkemper, Pathologie PathoTres, Berlin; Thomas F.E. Barth, University Medical Center Ulm; Stephan Stilgenbauer, University of Ulm, Ulm; Michael Hallek, Universität zu Köln, Köln; Ursula Vehling-Kaiser, Tagesklinik Hämatologie Onkologie, Landshut; Lothar Kanz, University of Tübingen, Tübingen; Michael Pfreundschuh, Universitätsklinik des Saarlandes, Homburg; Wolfram Klapper, University of Kiel, Kiel, Germany; Françoise Berger, LYSA Group; Nicole Brousse, Hopital Necker; Catherine Thieblemont, Hôpital Saint Louis; Olivier Hermine, University Paris Descartes; Olivier Hermine, Université Sorbonne Paris Cité, Paris; Bertrand Coiffier, Centre Hospitalier Lyon-Sud, Pierre-Bénite; Réda Bouabdallah, Service d'Hématologie, Marseille; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Stefano Pileri, University of Bologna, Bologna, Italy; Grzegorz Rymkiewicz, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Roman Kodet, Charles University, Prague, Czech Republic; and Johanna C. Kluin-Nelemans, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8387DOI Listing
April 2016

[Palliative and terminal care: doctors have to face the discussion].

Dtsch Med Wochenschr 2016 Mar 16;141(6):388. Epub 2016 Mar 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0042-103454DOI Listing
March 2016

An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.

PLoS One 2015 20;10(3):e0120925. Epub 2015 Mar 20.

Group Apoptosis, Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Oncology, Dr von Haunersches Kinderspital, Ludwig Maximilians-Universität (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120925PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368518PMC
February 2016

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

PLoS One 2014 9;9(10):e109759. Epub 2014 Oct 9.

Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Munich Großhadern, Ludwig-Maximilian-University (LMU), Munich, Germany; Clinical Cooperative Group Pathogenesis of Acute Myeloid Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109759PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192029PMC
December 2015

[Cancer screening - useful but not so easy].

Dtsch Med Wochenschr 2015 Sep 24;140(19):1424. Epub 2015 Sep 24.

Medizinische Klinik und Poliklinik III am Klinikum der Universität München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0041-106027DOI Listing
September 2015

The role of therapeutic leukapheresis in hyperleukocytotic AML.

PLoS One 2014 14;9(4):e95062. Epub 2014 Apr 14.

Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich - Campus Groβhadern, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/112a5734d6424c631a86fb83
Web Search
http://dx.plos.org/10.1371/journal.pone.0095062
Publisher Site
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0095062PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986260PMC
May 2015

Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.

Br J Haematol 2015 Feb 8;168(4):606-10. Epub 2014 Oct 8.

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Germany; Helmholtz Zentrum München - German Research Center for Environmental Health, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13132DOI Listing
February 2015

What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key.

Oncologist 2015 Jan 31;20(1):56-61. Epub 2014 Oct 31.

Department of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294613PMC
January 2015

Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.

PLoS One 2014 7;9(3):e89560. Epub 2014 Mar 7.

Department of Internal Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich, Germany; Clinical Cooperative Group Leukemia, Helmholtz Center Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089560PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946485PMC
December 2014

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.

Blood 2014 Aug 12;124(8):1304-11. Epub 2014 Jun 12.

Department of Internal Medicine 3, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany; Clinical Cooperative Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-12-540716DOI Listing
August 2014

Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML.

Leuk Res 2014 Aug 2;38(8):964-9. Epub 2014 Jun 2.

Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany; Clinical Co-Operation Group Immunotherapy at the Helmholtz Institute Munich, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.05.014DOI Listing
August 2014

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

J Clin Oncol 2014 May 31;32(13):1338-46. Epub 2014 Mar 31.

Eva Hoster, Roswitha Forstpointner, Wolfgang Hiddemann, Martin H. Dreyling, and Michael Unterhalt, University Hospital Munich; Eva Hoster, University of Munich, Munich; Wolfram Klapper, University of Kiel; Christiane Pott, University Hospital Schleswig-Holstein, Kiel; Michael Hallek, Universität Köln, Köln; Stephan Stilgenbauer, University of Ulm, Ulm, Germany; Olivier Hermine, University Paris Descartes and Université Sorbonne Paris Cité; Catherine Thieblemont, Hôpital Saint Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Hanneke C. Kluin-Nelemans, University of Groningen, Groningen; Jeanette Doorduijn, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Jan Walewski and Michal Szymczyk, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland; Achiel van Hoof, A. Z. Sint Jan AV, Brugge, Belgium; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Christian H. Geisler, Rigshospitalet, Copenhagen, Denmark; and Francesco Di Raimondo, University of Catania, Italy.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/28/JCO.2013.52
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.52.2466
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.52.2466DOI Listing
May 2014

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

J Clin Oncol 2014 May 7;32(15):1586-94. Epub 2014 Apr 7.

Friederike Pastore, Annika Dufour, Tobias Benthaus, Klaus H. Metzeler, Stephanie Schneider, Bianka Ksienzyk, Gudrun Mellert, Evelyn Zellmeier, Purvi M. Kakadia, Michael Unterhalt, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann, and Eva Hoster, University Hospital Munich Großhadern; Friederike Pastore, Klaus H. Metzeler, Wolfgang Hiddemann, Stefan K. Bohlander, and Karsten Spiekermann, Helmholtz Center Munich; Eva Hoster, University of Munich, Munich; Purvi M. Kakadia and Stefan K. Bohlander, University Hospital Marburg, Marburg; Michaela Feuring-Buske, University Hospital Ulm; Christian Buske, Comprehensive Cancer Center Ulm, University of Ulm, Ulm; Jan Braess, Klinikum Barmherzige Brüder, Regensburg; Maria Cristina Sauerland and Achim Heinecke, University of Muenster; Utz Krug, Wolfgang E. Berdel, and Thomas Buechner, University Hospital Muenster, Muenster; Bernhard Woermann, German Society of Hematology and Oncology, Berlin, Germany; Kati S. Maharry, Guido Marcucci, and Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Kati S. Maharry, Mayo Clinic, Rochester, MN; and Stefan K. Bohlander, University of Auckland, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/04/03/JCO.2013.52
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.52.3480
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.52.3480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876345PMC
May 2014

Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.

Bone Marrow Res 2014 3;2014:541345. Epub 2014 Apr 3.

Laboratory of Immunogenetics, Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology, University Hospital of Munich, Ludwig Maximilians University, Max-Lebsche-Platz 32, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/541345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996364PMC
May 2014